AIMS A six year prospective cohort study was conducted to clarify whether the current carbon disulphide (CS2) exposure level is low enough to prevent subclinical health impairment and/or to ameliorate health effects due to previous high exposure. This paper describes the effects on the cardiovascular systems. METHODS The study subjects were 432 male workers exposed to CS2 and 402 non-exposed ...

Abstract Diabetic retinopathy (DR) is one of the leading causes blindness for people suffering from diabetes. Microaneurysm (MA) initial symptom DR. MA a lesion based disease which starts as small red spots on retina and increases in size DR progresses finally leads to blindness. So eliminating can effectively prevent at an early stage. However, due complex retinal structure, different brightne...

Forty five insulin dependent diabetics were randomised to treatment with continuous subcutaneous insulin infusion (CSII), multiple insulin injections (five or six daily), or conventional twice daily insulin injections. Near normoglycaemia was obtained with CSII and multiple injections but not with conventional treatment (p less than 0.01). Hypoglycaemic coma was observed less frequently with CS...

The visual effects of carbon disulfide exposure were studied in macaque monkeys with measurements of visual thresholds, fluorescein angiography and fundus photography. Five monkeys were exposed by inhalation for 6 hr a day, 5 days a week to 256 ppm carbon disulfide (CS2). The motor dysfunction observed in these monkeys appeared to be entirely reversible. All five suffered severe reductions in v...

Introduction: Diabetic retinopathy (DR) is one of the most serious and most frequent eye diseases in the world and the most common cause of blindness in adults between 20 and 60 years of age. Following 15 years of diabetes, about 2% of the diabetic patients are blind and 10% suffer from vision impairment due to DR complications. This paper addresses the automatic detection of microaneurysms (MA...